None listed
Conditions
Interventions
Drug : All subjects will take 2 capsulus of Hwangryunhaedok-tang(Redoxin Cap.), 3 times a day, 30 minutes after meals, for 8 weeks.
Sponsors
Pusan National University Korean Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Only those aged 19 or over but under 65 2) Body mass index (BMI) of more than 25 kg / m2 3) Those who have been diagnosed with gastritis by gastroscopy 4) After fully hearing and understanding the details of this clinical trial, you agree to participate voluntarily and agree in writing to abide by the instructions. 5) Those who can follow up during the clinical trial
Exclusion criteria
Exclusion criteria: 1) Those who can not undergo gastroscopy 2) peptic ulcer (except patients with scarring) 3) Those who have had past gastric acid secretion surgery or stomach and esophagus surgery 4) A person with a history of gastrointestinal malignancies 5) In the second week prior to administration of test drug, H2 receptor antagonist, anticholinergic agent (muscarinic receptor antagonist), gastrin receptor antagonist, prostaglandin agent, proton pump inhibitor, gastric mucosal protective agent, One who took it 6) Those who need to continue taking medications that may affect this test, such as corticosteroids, non-steroidal anti-inflammatory drugs, and aspirin 7) Those taking thrombolytic agents (such as cerebral thrombosis, myocardial infarction, thrombophlebitis), consuming coagulation disorder patients and antithrombotic agents such as warfarin 8) People with Zollinger-Ellison syndrome 9) Those with a history of drug allergy symptoms (rash, fever, itching, etc.) 10) Patients with abnormal liver function and renal function with serum AST, ALT and creatinine> 3 times the normal peak 11) Those who have serious obstacles such as liver, kidney, heart, lung, blood 12) Those who are pregnant or breastfeeding, those who are pregnant, those who have a pregnancy plan or do not agree to the appropriate method of contraception 13) Those who have severe mental illnesses such as depression, anxiety disorder, or are currently taking psychotropic drugs such as antidepressants 14) Drug or alcohol addict 15) Those taking medicines or health functional foods that may affect the clinical trial 16) Smokers whose average daily smoking amount exceeds 10 per day during the past 3 months 17) Those who continue to drink (21 units / week, 1 unit = 10 g of pure alcohol) Example> Beer 5 ° 1 cup (250 ml) = 10 g, soju 20 ° 1 cup (50 ml) = 8 g, wine 12 ° 1 cup (125 ml) = 12 g 18) Any person judged by the examiner to be inappropriate for other examinations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the improvement rates of gastritis symptoms | — |
Secondary
| Measure | Time frame |
|---|---|
| Body composition test | — |
Countries
Korea, Republic of
Contacts
Public ContactHeeyeon Kim
Pusan National University Korean Medicine Hospital
Outcome results
None listed